Real-Life Education Made Simple: STI Adopts DepEd’s Enhanced SHS Program To Introduce Flexible Electives

STI’s Education for Real Life philosophy continues with a program designed to help students learn with clearer purpose.

Palme d’or And Beyond: The Complete 79th Cannes Winners List

The 79th Festival de Cannes closed its Competition by honoring powerful films, standout performances, and visionary filmmakers from across the global cinema landscape.

What Sskait Means In 2025 And Beyond

Sskait continues to grow beyond trends, showing how Filipino humor, storytelling, and community can build a lasting digital legacy for readers.

Penélope Cruz On LGBTQ+ Cinema And Almodóvar

Penélope Cruz used Cannes to speak about LGBTQ+ stories, fairness, and how cinema can carry convictions beyond the screen.

PH Eyes More Vaccine Brands For Pediatric Population

The government is coordinating with other drug manufacturers to expand the emergency use authorization of Covid-19 vaccines for children.

PH Eyes More Vaccine Brands For Pediatric Population

51
51

How do you feel about this story?

Like
Love
Haha
Wow
Sad
Angry

The government is coordinating with other drug manufacturers to expand the emergency use authorization (EUA) of coronavirus disease 2019 (Covid-19) vaccines for pediatric vaccination.

National Task Force (NTF) Against Covid-19 chief implementer, Secretary, Carlito Galvez Jr., said they are eyeing the use of other brands of coronavirus jabs for the younger population.

“Kami po ay nakipag-ugnayan na po sa ibang mga brand para po magkaroon po tayo ng EUA dito po sa ages 3 to 11 (We are coordinating with other brand manufacturers so that we can have EUA for ages 3 to 11 years old),” Galvez reported to President Rodrigo Duterte during the prerecorded Talk to the People aired on state-run People’s Television Network late Monday night.

The Food and Drug Administration has already approved the use of Pfizer-BioNTech and Moderna vaccines for the 12 to 17 age bracket.

Galvez said the government targets to start the administration of primary doses to some 12.5 million minors aged 5 to 11 years old within the second quarter this year.

The lower dosages of the Pfizer vaccine for the age bracket “might be available by the end of January,” according to Galvez.

About 11.11 million aged zero to four years old may also be inoculated by April while some 10.2 million children in the 12 to 17 age group should have already received booster doses by June. (PNA)